Market Overview:
The global veterinary molecular diagnostics market reached a value of US$ 581.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,064.1 Million by 2027 exhibiting a CAGR of 9.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Veterinary molecular diagnostics assist clinicians in detecting, identifying, and genotyping a broad range of viral, bacterial, and vector-borne pathogens among animals using molecular-based methods, such as conventional and quantitative polymerase chain reaction (PCR). They require small amounts of a diverse spectrum of biological sample types, which further allow rapid and highly sensitive detection of nucleic acids and diagnosis of infectious diseases. At present, an array of molecular techniques of different complexity are used in veterinary health centers and research laboratories to facilitate the fast and specific diagnosis of animal diseases.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Veterinary Molecular Diagnostics Market Trends:
The escalating number of animal husbandry activities, along with the rising concerns about food safety, represents one of the major factors catalyzing the demand for veterinary molecular diagnostics for better diagnosis and treatment of livestock. Additionally, the outbreak of coronavirus disease (COVID-19) across the globe is driving the need for PCR testing to analyze the effect of the infection in animals. Apart from this, the increasing pet ownership on account of the emerging nuclear family trends and inflating income levels, coupled with the rising pet humanization, is bolstering the market growth. This can also be attributed to the increasing uptake of pet insurance policies due to the growing concerns among pet parents about the well-being of their pets. Moreover, governing agencies of numerous countries are supporting veterinary practices and commercial animal-production programs, which, in turn, is strengthening the adoption of veterinary molecular diagnostics around the world. Besides this, the introduction of advanced genotyping techniques, such as whole-genome sequencing (WGS), in confluence with the surging demand for customized reagents and kits, is anticipated to influence the market positively.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary molecular diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, animal type, disease type and end user.
Breakup by Product:
- Kits and Reagents
- Instruments
- Software and Services
Breakup by Technology:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Real Time PCR
- Microarray
- DNA Sequencing
Breakup by Animal Type:
- Companion Animal
- Livestock Animal
Breakup by Disease Type:
- Vector-borne Diseases
- Respiratory Pathogens
- Diarrhea Pathogens
- Others
Breakup by End User:
- Veterinary Hospitals
- Clinical Laboratories
- Research Institutes
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biochek B.V., bioMérieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc. and Zoetis Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Product, Technology, Animal Type, Disease Type, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Biochek B.V., bioMérieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc. and Zoetis Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global veterinary molecular diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the animal type?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global veterinary molecular diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Veterinary Molecular Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Real Time PCR
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Microarray
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 DNA Sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Animal Type
8.1 Companion Animal
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Livestock Animal
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Disease Type
9.1 Vector-borne Diseases
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Respiratory Pathogens
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diarrhea Pathogens
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Veterinary Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinical Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Research Institutes
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Biochek B.V.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 bioMérieux SA
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 HealthGene Corporation
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Heska Corporation
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 IDEXX Laboratories Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 INDICAL BIOSCIENCE GmbH
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Ingenetix GmbH
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 NEOGEN Corporation
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Qiagen N.V
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Thermo Fisher Scientific Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Veterinary Molecular Diagnostics Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Zoetis Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2021
Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2021
Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2021
Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2021
Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million US$), 2022-2027
Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players